20/20 BIOLABS, INC.: depreciation_amortization
| Value | {"amount": 116035, "concept": "us-gaap:DepreciationDepletionAndAmortization", "currency": "USD"} |
|---|---|
| Period | 2024-01-01 – 2024-12-31 |
| Status | current |
| Entity | 20/20 BIOLABS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T11:27:01.038089+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/4e6c1cac-d83f-43d0-9a9a-bc488feb5be4
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001213900-26-037667 · Open the official SEC filing →Retrieved: 2026-08-19T11:27:01.038089+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001139685/depreciation-amortization/2024-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/4e6c1cac-d83f-43d0-9a9a-bc488feb5be4
History
- no predecessors — first report